STOCK TITAN
  1. Home
  2. Sec-filings
  3. OBIO
  4. [144] Orchestra BioMed Holdings, Inc. SEC Filing

Orchestra BioMed insider plans 15,000-share sale

Orchestra BioMed Holdings, Inc. (OBIO) insider Darren Sherman has filed a Form 144 indicating an intent to sell up to 15,000 shares of common stock through Fidelity Brokerage Services LLC on or after September 1, 2026.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. (OBIO) insider Darren Sherman has filed a Form 144 indicating an intent to sell up to 15,000 shares of common stock through Fidelity Brokerage Services LLC on or after September 1, 2026. The shares relate to restricted stock vesting on November 25, 2024 and are characterized as compensation.

Over the prior three months, Darren Sherman reported Rule 144 sales of 15,000 shares of OBIO common stock in each of June, July, and August 2026, with aggregate proceeds of $58,049.53, $64,066.02, and $61,291.68, respectively.

Positive

  • None.

Negative

  • None.
Shares to be sold 15,000 shares of Common Planned sale under Form 144 through Fidelity Brokerage Services LLC
Aggregate market value of securities to be sold $75,300.00 Valuation associated with the 15,000 OBIO shares in the Form 144
Shares sold June 1, 2026 15,000 shares for $58,049.53 Common stock sale reported for the past 3 months section
Shares sold July 1, 2026 15,000 shares for $64,066.02 Common stock sale reported for the past 3 months section
Shares sold August 3, 2026 15,000 shares for $61,291.68 Common stock sale reported for the past 3 months section
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"Common | 11/25/2024 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
attorney-in-fact regulatory
"as attorney-in-fact for Darren Sherman"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does Darren Sherman’s Form 144 filing mean for OBIO?
The filing states that Darren Sherman plans to sell up to 15,000 OBIO common shares under Rule 144 through Fidelity Brokerage Services LLC, based on restricted stock that vested on November 25, 2024. It is a notice of a potential sale, not confirmation of execution.

How many OBIO shares is Darren Sherman planning to sell in this Form 144?
The Form 144 indicates a planned sale of up to 15,000 shares of Orchestra BioMed Holdings, Inc. common stock. The filing lists an aggregate market value of $75,300.00 for these shares as of the filing information provided.

What OBIO share sales has Darren Sherman reported in the past three months?
Over the past three months, Darren Sherman reported sales of 15,000 OBIO shares on June 1, 2026 for $58,049.53, 15,000 shares on July 1, 2026 for $64,066.02, and 15,000 shares on August 3, 2026 for $61,291.68.

What is the source of the OBIO shares Darren Sherman plans to sell?
The Form 144 describes the securities to be sold as Common stock received from restricted stock vesting on November 25, 2024, with the issuer identified as Orchestra BioMed Holdings, Inc. and the transaction type labeled as Compensation.

Who is executing the planned OBIO share sale for Darren Sherman?
The planned sale of 15,000 OBIO common shares is listed through Fidelity Brokerage Services LLC. The Form 144 is signed by Jennifer Ruchti as a duly authorized representative of Fidelity, acting as attorney-in-fact for Darren Sherman.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR